Molecule intelOpportunity: Lower0

Acitretin

34 brands · 24 companies · product forms

Opportunity snapshot

Launch attractiveness
24
Market saturation
63
Price room
71
Regulatory risk
0
34
brands
24
companies
Rs 1,194.7
median price
26
price points
3.85x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 9%

Price room

Across observed sources and strengths
CheapestRs 721.07
MedianRs 1,194.7
Most expensiveRs 2,773.98
Spread3.85×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 3.85x across 26 trusted points (Rs 721.07-2773.98). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 10 live products for Acitretin — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(71) + 20% low-competition(37) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

24 canonical companies and 34 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 3.85x across 26 trusted points (Rs 721.07-2773.98). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.